U.S. FDA Approves INVOKANA? (Canagliflozin) for the Treatment of Adults with Type 2 Diabetes(Mar 29, 2013)

RARITAN, N.J., March 29, 2013 ? Janssen Pharmaceuticals, Inc. announced today the U.S. Food and Drug Administration (FDA) has approved INVOKANA? (canagliflozin) for the treatment of adults with type 2 diabetes. INVOKANA? is the first in a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors to be approved in the United States. It is also the only oral, once-daily medication available in the United States offering improved glycemic control while also showing reduced body weight and systolic blood pressure in clinical trials.....
Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news